SMAD3 and rheumatoid arthritis: This prediction of multiprotein interactions also finds indirect support in the differential expression of the known IRF1 and SMAD3 interactors in BIRC5hiCD4+ cells of patients with RA (Figures 5G, S5B, and S5C).